Company Filing History:
1 out of 832,912 Years Active: 2001
Title: Michael C O Krause: Innovator in Histamine Receptor Research
Introduction
Michael C O Krause is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with histamine receptors. His work has implications for various therapeutic applications.
Latest Patents
Krause holds a patent for "Imidazole derivatives as histamine receptor H3 (ANT) agonists." This patent details novel imidazole derivatives that serve as histamine receptor antagonists and/or agonists. The patent outlines the preparation of these compounds and their therapeutic uses. It also describes chemical compounds that can function as histamine receptor H3 agonists, partial agonists, or antagonists, characterized by general formulas (Ia) or (Ib). The patent further discusses methods for revealing the agonist, partial agonist, or antagonist activity of such compounds in vivo.
Career Highlights
Throughout his career, Krause has focused on the development of innovative chemical compounds that can be utilized in drug formulation. His research has contributed to a deeper understanding of histamine receptors and their role in various physiological processes.
Collaborations
Krause has collaborated with esteemed colleagues such as Jean-Charles Schwartz and Jean-Michel Arrang. These partnerships have enhanced the scope and impact of his research in the field.
Conclusion
Michael C O Krause is a prominent figure in the realm of histamine receptor research, with a patent that showcases his innovative approach to drug development. His contributions continue to influence the pharmaceutical industry and pave the way for future advancements.